Diagnostic News and Research

RSS

Scans, hospital infections at heart of new quality issues

A new diagnostic imaging test that can detect plaque in the arteries of the heart is not an efficient tool for screening people not experiencing symptoms of heart disease, a recent study found.

1 Jun 2011

$Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients$

Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients

Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated with higher risk of fracture compared to persons without DM, according to a study in the June 1 issue of JAMA.

1 Jun 2011

Women with ovarian cancer could benefit from new targeted testing

Women with ovarian cancer could be helped by a new test that identifies the specific type of tumour they have, a conference will hear this week.

1 Jun 2011

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

After years of building hope for a treatment, Rochester researchers and clinicians will begin the first controlled clinical trial for Juvenile Batten disease this summer, thanks to $1 million in grants from the Food and Drug Administration and the Batten Disease Support and Research Association.

1 Jun 2011

Complementary technologies for rapid EHEC identification and detection

With the recent outbreak in Europe of Enterohaemorrhagic Escherichia coli (EHEC), Roche Applied Science and TIB Molbiol are providing scientists with complementary technologies that can be used for the rapid identification and detection of EHEC.

30 May 2011

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Augurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism Conference, leading arthritis researchers presented important data on Augurex's rheumatoid arthritis biomarker blood test and novel drug target.

30 May 2011

Preparticipation cardiac screening required for college athletes

Sudden cardiac death in young athletes who had not previously exhibited symptoms is a relatively rare yet tragic event. This occurs in around 60-80 young athletes annually in the United States.

27 May 2011

Phadia ImmunoCAP Specific IgE blood test used in largest cross-sectional allergy study

Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.

27 May 2011

OVA1 more effective than CA 125 test in evaluating likelihood of ovarian cancer

A paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment of a woman's ovarian mass would identify more ovarian cancers than a physician's preoperative assessment alone.

From Quest Diagnostics 27 May 2011

ASH announces approval of official health care taxonomy code for Designated Specialists

Today the American Society of Hypertension, Inc. (ASH) and the ASH Specialist Program Inc. announced the approval of an official health care taxonomy code for Designated Specialists in Clinical Hypertension from the American Medical Association National Uniform Claims Committee.

27 May 2011

Transgenomic secures exclusive license from Montefiore for cancer predictive markers

Transgenomic, Inc. announced today that it has acquired an exclusive worldwide license to Montefiore Medical Center's patent application, "Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including cetuximab, panitumumab and erlotinib".

27 May 2011

Quest Diagnostics announces results of largest ImmunoCAP cross-sectional allergy study

ImmunoCAP, the worldwide leader of in vitro allergy diagnostics, is pleased to present the results of the largest cross-sectional allergy study ever conducted. The landmark study, announced today by Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information, and services, includes test results from over 2 million patients.

From Quest Diagnostics 27 May 2011

Johns Hopkins announces establishment of new institute for patient safety and quality

Recognizing the urgent need to advance the science of reducing preventable harm and improve health care quality, Johns Hopkins Medicine is announcing the establishment of the Armstrong Institute for Patient Safety and Quality, an organization whose work will benefit not only Johns Hopkins patients but those around the world.

27 May 2011

Gestational high-fat diet programs woman's baby for future diabetes

A high-fat diet during pregnancy may program a woman's baby for future diabetes, even if she herself is not obese or diabetic, says a new University of Illinois study published in the Journal of Physiology.

26 May 2011

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.

26 May 2011

U-M develops new tool that helps physicians better evaluate patient's depression outcomes

Primary care doctors have long been on the front lines of depression treatment. Depression is listed as a diagnosis for 1 in 10 office visits and primary care doctors prescribe more than half of all antidepressants.

26 May 2011

Consistency and efficiency of FDA's medical device review process raises concern

Two-thirds of small medical device and diagnostic companies--the drivers of innovation in the sector--are obtaining clearance for new products in Europe first, suggesting delayed market entry in the U.S., according to a comprehensive industrywide survey about FDA's 510(k) product review process by researchers at Northwestern University.

26 May 2011

Neoprobe, Devicor sign gamma detection device asset purchase agreement

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has signed a definitive asset purchase agreement to sell its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in cash, plus a contingent value provision for payment to Neoprobe of up to an additional $20 million in royalties.

26 May 2011

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues.

25 May 2011

MIT, GE partner to create Medical Electronic Device Realization Center

Supporting its quest through healthymagination to reach more patients with better health care globally, GE has joined with the Massachusetts Institute of Technology (MIT) to create a Medical Electronic Device Realization Center at MIT.

25 May 2011

Diagnostic News and Research

Scans, hospital infections at heart of new quality issues

Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients

Women with ovarian cancer could benefit from new targeted testing

Rochester receives $1M FDA, BDRSA grant to begin first controlled clinical trial in Juvenile Batten disease

Complementary technologies for rapid EHEC identification and detection

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Preparticipation cardiac screening required for college athletes

Phadia ImmunoCAP Specific IgE blood test used in largest cross-sectional allergy study

OVA1 more effective than CA 125 test in evaluating likelihood of ovarian cancer

ASH announces approval of official health care taxonomy code for Designated Specialists

Transgenomic secures exclusive license from Montefiore for cancer predictive markers

Quest Diagnostics announces results of largest ImmunoCAP cross-sectional allergy study

Johns Hopkins announces establishment of new institute for patient safety and quality

Gestational high-fat diet programs woman's baby for future diabetes

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

U-M develops new tool that helps physicians better evaluate patient's depression outcomes

Consistency and efficiency of FDA's medical device review process raises concern

Neoprobe, Devicor sign gamma detection device asset purchase agreement

Scientists develop quick, low-cost microchip for immune monitoring and clinical applications

MIT, GE partner to create Medical Electronic Device Realization Center

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News